Targeted Oncology
Advertisement
Articles by Targeted Oncology
Shared insight on recent advances in KRAS-mutant NSCLC, with a focus on new therapies on the horizon.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
2
What Stood Out at IMS 2026? Five Myeloma Experts Weigh In
3
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
4
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer
5